The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
And I merely told KMunnelly what I know. I am a III investor and for ten years have simply obtained a LOR and turned up. Given the venue size I checked with Wendy and no different to usual. So I told him not to email Wendy therefore....and gave him the info as to how to get his TOR as I know the company. No reference to you at all and certainly no size 10. You however chose to interpret it thus and replied with sarcasm and a daft analogy.
You seem to be a very new poster....1 post in fact according to LSE so you are either new, or you are one of those pests that constantly reappears with a new name but remains as petulant in each incarnation.
I did not mention your post and I did not link my post to yours.
Hope to meet you at the AGM.
Kmunnelly
Don't email Wendy...she can't action what you need.
Go to the secure messaging section of your account on II. Send a secure message telling them you need a letter of representation for the AFC AGM. They will send it usually within 48 hours. I have found them very efficient. Then you just take it with you to the AGM>
Accepted Jim. It's a very crude analysis on my part. But Ceres also have a big cash pile.
Extending the crude analysis a year ago Ceres has a prospective T/O of £32m. Let's ignore that their MCap then was well over £2Bn and use today's rounded figure of £1.5Bn. That gives a prospective MCap/TO ratio of 47. Apply that to the AFC estimated 2022 TO of £11m gives an estimated 2022 MCap of £517m. Which is a share price of 70p, so you can argue that that is where we should be now.
Before |I'm shot down in flames, I know this is very simplistic.